Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Tollefson, GD' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 104 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Faries, DE; Heiligenstein, JH; Tollefson, GD; Potter, WZ
      The double-blind variable placebo lead-in period: Results from two antidepressant clinical trials

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    2. Basson, BR; Kinon, BJ; Taylor, CC; Szymanski, KA; Gilmore, JA; Tollefson, GD
      Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

      JOURNAL OF CLINICAL PSYCHIATRY
    3. Kinon, BJ; Basson, BR; Gilmore, JA; Tollefson, GD
      Long-term olanzapine treatment: Weight change and weight-related health factors in schizophrenia

      JOURNAL OF CLINICAL PSYCHIATRY
    4. Dossenbach, MRK; Kratky, P; Schneidman, M; Grundy, SL; Metcalfe, S; Tollefson, GD; Belmaker, RH
      Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone

      JOURNAL OF CLINICAL PSYCHIATRY
    5. Casper, RC; Tollefson, GD; Nilsson, ME
      No gender differences in placebo responses of patients with major depressive disorder

      BIOLOGICAL PSYCHIATRY
    6. Tollefson, GD; Birkett, MA; Kiesler, GM; Wood, AJ
      Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine

      BIOLOGICAL PSYCHIATRY
    7. Shelton, RC; Tollefson, GD; Tohen, M; Stahl, S; Gannon, KS; Jacobs, TG; Buras, WR; Bymaster, FP; Zhang, W; Spencer, KA; Feldman, PD; Meltzer, HY
      A novel augmentation strategy for treating resistant major depression

      AMERICAN JOURNAL OF PSYCHIATRY
    8. Zhang, W; Perry, KW; Wong, DT; Potts, BD; Bao, JQ; Tollefson, GD; Bymaster, FP
      Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex

      NEUROPSYCHOPHARMACOLOGY
    9. Poyurovsky, M; Dorfman-Etrog, P; Hermesh, H; Munitz, H; Tollefson, GD; Weizman, A
      Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    10. Dossenbach, MRK; Beuzen, JN; Avnon, M; Belmaker, RH; Elizur, A; Mark, M; Munitz, H; Schneidman, M; Shoshani, D; Kratky, P; Grundy, SL; Tollefson, GD
      The effectiveness of olanzapine in treatment-refractory schizophrenia whenpatients are nonresponsive to or unable to tolerate clozapine

      CLINICAL THERAPEUTICS
    11. Street, JS; Tollefson, GD; Tohen, M; Sanger, TM; Clark, WS; Gannon, KS; Wei, HX
      Olanzapine for psychotic conditions in the elderly

      PSYCHIATRIC ANNALS
    12. Bech, P; Cialdella, P; Haugh, MC; Birkett, MA; Hours, A; Boissel, JP; Tollefson, GD
      Meta-analysis of randomised controlled trials of fluoxetine v. placebo andtricyclic antidepressants in the short-term treatment of major depression

      BRITISH JOURNAL OF PSYCHIATRY
    13. Tohen, M; Jacobs, TG; Grundy, SL; McElroy, SL; Banov, MC; Janicak, PG; Sanger, T; Risser, R; Zhang, F; Toma, V; Francis, J; Tollefson, GD; Breier, A
      Efficacy of olanzapine in acute bipolar mania - A double-blind, placebo-controlled study

      ARCHIVES OF GENERAL PSYCHIATRY
    14. Purdon, SE; Jones, BDW; Stip, E; Labelle, A; Addington, D; David, SR; Breier, A; Tollefson, GD
      Neuropsychological change in early phase schizophrenia during 12 months oftreatment with olanzapine, risperidone, or haloperidol

      ARCHIVES OF GENERAL PSYCHIATRY
    15. Street, JS; Clark, WS; Gannon, KS; Cummings, JL; Bymaster, FP; Tamura, RN; Mitan, SJ; Kadam, DL; Sanger, TM; Feldman, PD; Tollefson, GD; Breier, A
      Olanzapine treatment of psychotic and behavioral symptoms in patients withAlzheimer disease in nursing care facilities - A double-blind, randomized,placebo-controlled trial

      ARCHIVES OF GENERAL PSYCHIATRY
    16. Tollefson, GD; Sanger, TM
      Anxious-depressive symptoms in schizophrenia: a new treatment target for pharmacotherapy?

      SCHIZOPHRENIA RESEARCH
    17. Tollefson, GD; Dellva, MA; Mattler, CA; Kane, JM; Wirshing, DA; Kinon, BJ
      Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    18. Smith, WT; Londborg, PD; Blomgren, SL; Tollefson, GD; Sayler, ME
      Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxiety

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    19. Tollefson, GD; Andersen, SW
      Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?

      JOURNAL OF CLINICAL PSYCHIATRY
    20. Tollefson, GD
      Focus on schizophrenia - Introduction

      BRITISH JOURNAL OF PSYCHIATRY
    21. Tollefson, GD; Kuntz, AJ
      Review of recent clinical studies with olanzapine

      BRITISH JOURNAL OF PSYCHIATRY
    22. Tran, PV; Tollefson, GD; Sanger, TM; Lu, YL; Berg, PH; Beasley, CM
      Olanzapine versus haloperidol in the treatment of schizoaffective disorder- Acute and long-term therapy

      BRITISH JOURNAL OF PSYCHIATRY
    23. Beasley, CM; Dellva, MA; Tamura, RN; Morgenstern, H; Glazer, WM; Ferguson, K; Tollefson, GD
      Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

      BRITISH JOURNAL OF PSYCHIATRY
    24. Tollefson, GD; Andersen, SW; Tran, PV
      The course of depressive symptoms in predicting relapse in schizophrenia: A double-blind, randomized comparison of olanzapine and risperidone

      BIOLOGICAL PSYCHIATRY
    25. Tohen, M; Sanger, TM; McElroy, SL; Tollefson, GD; Chengappa, R; Daniel, DG; Petty, F; Centorrino, F; Wang, R; Grundy, SL; Greaney, MG; Jacobs, TG; David, SR; Toma, V
      Olanzapine versus placebo in the treatment of acute mania

      AMERICAN JOURNAL OF PSYCHIATRY
    26. Sanger, TM; Lieberman, JA; Tohen, M; Grundy, S; Beasley, C; Tollefson, GD
      Olanzapine versus haloperidol treatment in first-episode psychosis

      AMERICAN JOURNAL OF PSYCHIATRY
    27. Michelson, D; Lydiard, B; Pollack, MH; Tamura, RN; Hoog, SL; Tepner, R; Demitrack, MA; Tollefson, GD
      Outcome assessment and clinical improvement in panic disorder: Evidence from a randomized controlled trial of fluoxetine and placebo (vol 155, pg 1570, 1998)

      AMERICAN JOURNAL OF PSYCHIATRY
    28. BEASLEY CM; SAYLER ME; KIESLER GM; POTVIN JH; SANGER TM; TOLLEFSON GD
      THE INFLUENCE OF PHARMACOTHERAPY ON SELF-DIRECTED AND EXTERNALLY-DIRECTED AGGRESSION IN SCHIZOPHRENIA

      Schizophrenia research
    29. HAMILTON SH; REVICKI DA; GENDUSO LA; TOLLEFSON GD
      COSTS OF OLANZAPINE TREATMENT COMPARED WITH HALOPERIDOL FOR SCHIZOPHRENIA - RESULTS FROM A RANDOMIZED CLINICAL-TRIAL

      Schizophrenia research
    30. SANGER TM; LIEBERMAN JA; TOHEN M; TOLLEFSON GD
      OLANZAPINE VERSUS HALOPERIDOL IN THE TREATMENT OF FIRST EPISODE PSYCHOSIS

      Schizophrenia research
    31. SANGER TM; TOHEN M; TOLLEFSON GD; JACOBS T; DAVID S
      OLANZAPINE VS PLACEBO IN RAPID-CYCLING BIPOLAR DISORDER

      Schizophrenia research
    32. SANGER TM; TOHEN M; TOLLEFSON GD; MCELROY SL; GREANEY MG; TOMA V
      OLANZAPINE VS PLACEBO IN THE TREATMENT OF ACUTE MANIA

      Schizophrenia research
    33. TAMURA RN; BEASLEY CM; DELLVA MA; GLAZER WM; MORGENSTERN H; TOLLEFSON GD
      WHAT IS THE DIFFERENTIAL RISK OF TARDIVE-DYSKINESIA WITH THE NOVEL ANTIPSYCHOTIC OLANZAPINE

      Schizophrenia research
    34. JONES B; CRAWFORD AMK; BEASLEY CM; TOLLEFSON GD
      THE ACUTE AND LONG-TERM EFFECT OF OLANZAPINE COMPARED WITH PLACEBO AND HALOPERIDOL ON SERUM PROLACTIN CONCENTRATION

      Schizophrenia research
    35. TOLLEFSON GD; SANGER TM
      A BLINDED TRIAL ON THE COURSE AND RELATIONSHIP OF DEPRESSIVE SYMPTOMSIN SCHIZOPHRENIA

      Schizophrenia research
    36. TRAN PV; TOLLEFSON GD; ANDERSEN SW; KUNTZ AJ; HAMILTON SH
      OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS

      Schizophrenia research
    37. WRIGHT P; TOLLEFSON GD; BEASLEY CM; TAMURA RN; TRAN PV; POTVIN JII
      A BLINDED, CONTROLLED, LONG-TERM STUDY OF THE COMPARATIVE INCIDENCE OF TREATMENT - EMERGENT TARDIVE-DYSKINESIA WITH OLANZAPINE OR HALOPERIDOL

      Schizophrenia research
    38. TOLLEFSON GD; TRAN PV
      COMMENTS ON DOUBLE-BLIND COMPARISON OF OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS BY TRAN AND ASSOCIATES - REPLY TO KASPER AND KUFFERLE

      Journal of clinical psychopharmacology
    39. TOLLEFSON GD; TRAN PV
      COMMENTS ON ARTICLE BY TRAN AND COLLEAGUES, DOUBLE-BLIND COMPARISON OF OLANZAPINE VERSUS RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS - REPLY - LETTER TO THE EDITOR

      Journal of clinical psychopharmacology
    40. TOLLEFSON GD; TRAN PV
      COMMENTS ON ARTICLE BY TRAN AND ASSOCIATES, DOUBLE-BLIND COMPARISON OF OLANZAPINE VERSUS RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS - REPLY - LETTER TO THE EDITOR

      Journal of clinical psychopharmacology
    41. TRAN PV; DELLVA MA; TOLLEFSON GD; WENTLEY AL; BEASLEY CM
      ORAL OLANZAPINE VERSUS ORAL HALOPERIDOL IN THE MAINTENANCE TREATMENT OF SCHIZOPHRENIA AND RELATED PSYCHOSES

      British Journal of Psychiatry
    42. TOLLEFSON GD; SANGER TM; BEASLEY CM; TRAN PV
      A DOUBLE-BLIND, CONTROLLED COMPARISON OF THE NOVEL ANTIPSYCHOTIC OLANZAPINE VERSUS HALOPERIDOL OR PLACEBO ON ANXIOUS AND DEPRESSIVE SYMPTOMS ACCOMPANYING SCHIZOPHRENIA

      Biological psychiatry
    43. TRAN PV; JAKOVLJEVIC M; TOLLEFSON GD; CRAWFORD AM; DOSSENBACH M; FRIEDEL P; HOTUJAC L; FOLNEGOVIC V; UGLESIC B; DODIG G
      OLANZAPINE VS FLUPHENAZINE - TREATMENT OF ACUTE SCHIZOPHRENIC SYMPTOMATOLOGY AND ANXIETY

      Biological psychiatry
    44. TOLLEFSON GD; SANGER TM; LU YL; THIEME ME
      DEPRESSIVE SIGNS AND SYMPTOMS IN SCHIZOPHRENIA - A PROSPECTIVE BLINDED TRIAL OF OLANZAPINE AND HALOPERIDOL

      Archives of general psychiatry
    45. TOLLEFSON GD; SANGER TM; LU YL; THIEME ME
      DEPRESSIVE SIGNS AND SYMPTOMS IN SCHIZOPHRENIA - A PROSPECTIVE BLINDED TRIAL OF OLANZAPINE AND HALOPERIDOL (VOL 55, PG 250, 1998)

      Archives of general psychiatry
    46. TOLLEFSON GD; SANGER TM
      OLANZAPINE FOR PRIMARY NEGATIVE SYMPTOMS - REPLY

      The American journal of psychiatry
    47. MICHELSON D; LYDIARD B; POLLACK MH; TAMURA RN; HOOG SL; TEPNER R; DEMITRACK MA; TOLLEFSON GD
      OUTCOME ASSESSMENT AND CLINICAL IMPROVEMENT IN PANIC DISORDER - EVIDENCE FROM A RANDOMIZED CONTROLLED TRIAL OF FLUOXETINE AND PLACEBO

      The American journal of psychiatry
    48. TOLLEFSON GD; BEASLEY CM; KUNTZ AJ
      OLANZAPINE ON TRIAL - REPLY

      The American journal of psychiatry
    49. DELLVA MA; TRAN P; TOLLEFSON GD; WENTLEY AL; BEASLEY CM
      STANDARD OLANZAPINE VERSUS PLACEBO AND INEFFECTIVE DOSE OLANZAPINE INTHE MAINTENANCE TREATMENT OF SCHIZOPHRENIA

      Psychiatric services
    50. SCHNEIDER LS; SMALL GW; HAMILTON SH; BYSTRITSKY A; NEMEROFF CB; MEYERS BS; ABUZZAHAB FS; ALEXOPOULOS GS; BIELSKI RJ; BORISON RL; BROD MS; COHENCOLE SA; COHN CK; DOWNS JM; DUPONT RL; FERGUSON JM; FOLKS DG; GOTTLIEB GL; GRABER B; MENOLASCINO FJ; HALARIS AE; HARTFORD JT; HERTZMAN M; JEFFERSON JW; JESTE DV; KORAN LM; LAZARUS LW; NAKRA BRS; OXENKRUG GF; RAPPAPORT SA; ROSENTHAL MH; SALZMAN C; SHRIVASTAVA R; STOKES PE; WINSTON JL; WHEADON DW; SCHATZ EJ; MARVEL DE; ALBRITTON R; TOLLEFSON GD
      ESTROGEN REPLACEMENT AND RESPONSE TO FLUOXETINE IN A MULTICENTER GERIATRIC DEPRESSION TRIAL

      The American journal of geriatric psychiatry
    51. BEASLEY CM; HAMILTON SH; CRAWFORD AM; DELLVA MA; TOLLEFSON GD; TRAN PV; BLIN O; BEUZEN JN
      OLANZAPINE VERSUS HALOPERIDOL - ACUTE-PHASE RESULTS OF THE INTERNATIONAL DOUBLE-BLIND OLANZAPINE TRIAL

      European neuropsychopharmacology
    52. CRAWFORD AMK; BEASLEY CM; TOLLEFSON GD
      THE ACUTE AND LONG-TERM EFFECT OF OLANZAPINE COMPARED WITH PLACEBO AND HALOPERIDOL ON SERUM PROLACTIN CONCENTRATIONS

      Schizophrenia research
    53. TOLLEFSON GD; TRAN PV; HAMILTON S; KUNTZ A
      OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF PSYCHOSIS - PRELIMINARY-REPORT

      Schizophrenia research
    54. TOLLEFSON GD; TRAN PV; BIRKETT M; SHOSHANI D
      TREATMENT FAILURE WITH CLOZAPINE - CAN OLANZAPINE BE THE ALTERNATIVE THERAPY

      Schizophrenia research
    55. TOLLEFSON GD; LU YL; SANGER TM; BEASLEY CM; TRAN PV
      OLANZAPINE IN THE TREATMENT OF SCHIZOAFFECTIVE DISORDER

      Schizophrenia research
    56. TOLLEFSON GD; SANGER TM; BEASLEY CM
      THE COURSE OF PRIMARY AND SECONDARY NEGATIVE SYMPTOMS IN A CONTROLLEDTRIAL WITH OLANZAPINE

      Schizophrenia research
    57. TOLLEFSON GD; LU YL
      COMORBID MOOD DISTURBANCE IN SCHIZOPHRENIA

      Schizophrenia research
    58. TOLLEFSON GD; SANGER TM; LIEBERMAN JA
      OLANZAPINE VERSUS HALOPERIDOL IN THE TREATMENT OF FIRST EPISODE PSYCHOSIS

      Schizophrenia research
    59. TRAN PV; HAMILTON SH; KUNTZ AJ; POTVIN JH; ANDERSEN SW; BEASLEY C; TOLLEFSON GD
      DOUBLE-BLIND COMPARISON OF OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS

      Journal of clinical psychopharmacology
    60. TRAN PV; DELLVA MA; TOLLEFSON GD; BEASLEY CM; POTVIN JH; KIESLER GM
      EXTRAPYRAMIDAL SYMPTOMS AND TOLERABILITY OF OLANZAPINE VERSUS HALOPERIDOL IN THE ACUTE TREATMENT OF SCHIZOPHRENIA

      The Journal of clinical psychiatry
    61. BEASLEY CM; TOLLEFSON GD; TRAN PV
      EFFICACY OF OLANZAPINE - AN OVERVIEW OF PIVOTAL CLINICAL-TRIALS

      The Journal of clinical psychiatry
    62. BEASLEY CM; TOLLEFSON GD; TRAN PV
      SAFETY OF OLANZAPINE

      The Journal of clinical psychiatry
    63. TOLLEFSON GD
      CONCLUDING REMARKS

      The Journal of clinical psychiatry
    64. TOLLEFSON GD; TRAN PV; HAMILTON S; KUNTZ A
      OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF PSYCHOSIS - PRELIMINARY-REPORT

      Biological psychiatry
    65. TOLLEFSON GD; STREET J; TAMURA R; SANGER TM
      DYSKINETIC SYMPTOMS - OLANZAPINE VERSUS HALOPERIDOL

      Biological psychiatry
    66. TOLLEFSON GD; SANGER TD; LIEBERMAN JA
      OLANZAPINE VERSUS HALOPERIDOL IN THE TREATMENT OF FIRST EPISODE PSYCHOSIS

      Biological psychiatry
    67. TOLLEFSON GD; SAYLER ME; BLOMGREN SL
      THE COURSE OF PSYCHOMOTOR AGITATION DURING PHARMACOTHERAPY OF DEPRESSION - ANALYSIS FROM DOUBLE-BLIND, CONTROLLED TRIALS

      Biological psychiatry
    68. TOLLEFSON GD; LU Y
      COMORBID MOOD DISTURBANCE IN SCHIZOPHRENIA

      Biological psychiatry
    69. BODICK NC; OFFEN WW; LEVEY AI; CUTLER NR; GAUTHIER SG; SATLIN A; SHANNON HE; TOLLEFSON GD; RASMUSSEN K; BYMASTER FP; HURLEY DJ; POTTER WZ; PAUL SM
      EFFECTS OF XANOMELINE, A SELECTIVE MUSCARINIC RECEPTOR AGONIST, ON COGNITIVE FUNCTION AND BEHAVIORAL SYMPTOMS IN ALZHEIMER-DISEASE

      Archives of neurology
    70. TOLLEFSON GD; BEASLEY CM; TAMURA RN; TRAN PV; POTVIN JH
      BLIND, CONTROLLED, LONG-TERM STUDY OF THE COMPARATIVE INCIDENCE OF TREATMENT-EMERGENT TARDIVE-DYSKINESIA WITH OLANZAPINE OR HALOPERIDOL

      The American journal of psychiatry
    71. TOLLEFSON GD; BEASLEY CM; TRAN PV; STREET JS; KRUEGER JA; TAMURA RN; GRAFFEO KA; THIEME ME
      OLANZAPINE VERSUS HALOPERIDOL IN THE TREATMENT OF SCHIZOPHRENIA AND SCHIZOAFFECTIVE AND SCHIZOPHRENIFORM DISORDERS - RESULTS OF AN INTERNATIONAL COLLABORATIVE TRIAL

      The American journal of psychiatry
    72. TOLLEFSON GD; SANGER TM
      NEGATIVE SYMPTOMS - A PATH ANALYTIC APPROACH TO A DOUBLE-BLIND, PLACEBO-CONTROLLED AND HALOPERIDOL-CONTROLLED CLINICAL-TRIAL WITH OLANZAPINE

      The American journal of psychiatry
    73. TOLLEFSON GD; BEASLEY CM; TRAN PV; TAMURA RN; SANGER TM; WOOD A; BEUZEN JN
      OLANZAPINE VERSUS HALOPERIDOL - RESULTS OF THE MULTICENTER INTERNATIONAL TRIAL

      Schizophrenia research
    74. TOLLEFSON GD; HEILIGENSTEIN JH; TOLLEFSON SL; BIRKETT MA; KNIGHT DL; NEMEROFF CB
      IS THERE A RELATIONSHIP BETWEEN BASE-LINE AND TREATMENT-ASSOCIATED CHANGES IN [H-3]-IMI PLATELET BINDING AND CLINICAL-RESPONSE IN MAJOR DEPRESSION

      Neuropsychopharmacology
    75. TOLLEFSON GD
      COGNITIVE FUNCTION IN SCHIZOPHRENIC-PATIENTS

      The Journal of clinical psychiatry
    76. SMALL GW; BIRKETT M; MEYERS BS; KORAN LM; BYSTRITSKY A; NEMEROFF CB; ABUZZAHAB FS; ALEXOPOULOS GS; BIELSKI RJ; BORISON RL; BROD MS; COHENCOLE SA; COHN CK; DOWNS JM; DUPONT RL; FERGUSON JM; FOLKS DG; GOTTLIEB GL; GRABER B; MENOLASCINO FJ; HALARIS AE; HARTFORD JT; HERTZMAN M; JEFFERSON JW; JESTE DV; LAZARUS LW; NAKRA BR; OXENKRUG GF; RAPPAPORT SA; ROSENTHAL MH; SALZMAN C; SHRIVASTAVA RK; STOKES PE; WINSTON JL; WHEADON DW; SCHATZ EJ; MARVEL DE; ALBRITTON R; TOLLEFSON GD; LILLY E
      IMPACT OF PHYSICAL ILLNESS ON QUALITY-OF-LIFE AND ANTIDEPRESSANT RESPONSE IN GERIATRIC MAJOR DEPRESSION

      Journal of the American Geriatrics Society
    77. GOLDSTEIN DJ; RAMPEY AH; ROBACK PJ; WILSON MG; HAMILTON SH; SAYLER ME; TOLLEFSON GD
      EFFICACY AND SAFETY OF LONG-TERM FLUOXETINE TREATMENT OF OBESITY - MAXIMIZING SUCCESS

      Obesity research
    78. TRAN PV; BEASLEY CM; TOLLEFSON GD; BEUZEN JN; HOLMAN SL; SANGER TM; SATTERLEE WG
      OLANZAPINE - A PROMISING ATYPICAL ANTIPSYCHOTIC AGENT

      Schizophrenia research
    79. KORAN LM; HAMILTON SH; HERTZMAN M; MEYERS BS; HALARIS AE; TOLLEFSON GD; DOWNS JM; FOLKS DG; JESTE DV; LAZARUS LW; SATLIN A
      PREDICTING RESPONSE TO FLUOXETINE IN GERIATRIC-PATIENTS WITH MAJOR DEPRESSION

      Journal of clinical psychopharmacology
    80. BLOMGREN SL; TOLLEFSON GD
      FLUOXETINE

      The New England journal of medicine
    81. HARRISON DA; SATTERLEE W; TRAN P; BEASLEY CM; TOLLEFSON GD
      OLANZAPINE - A POTENTIAL ATYPICAL ANTIPSYCHOTIC AGENT - PHASE-II CLINICAL FINDINGS

      Schizophrenia research
    82. TOLLEFSON GD; GREIST JH; JEFFERSON JW; HEILIGENSTEIN JH; SAYLER ME; TOLLEFSON SL; KOBACK K
      IS BASE-LINE AGITATION A RELATIVE CONTRAINDICATION FOR A SELECTIVE SEROTONIN REUPTAKE INHIBITOR - A COMPARATIVE TRIAL OF FLUOXETINE VERSUS IMIPRAMINE

      Journal of clinical psychopharmacology
    83. TOLLEFSON GD; RAMPEY AH; BEASLEY CM; ENAS GG; POTVIN JH
      ABSENCE OF A RELATIONSHIP BETWEEN ADVERSE EVENTS AND SUICIDALITY DURING PHARMACOTHERAPY FOR DEPRESSION

      Journal of clinical psychopharmacology
    84. TOLLEFSON GD; HOLMAN SL
      HOW LONG TO ONSET OF ANTIDEPRESSANT ACTION - A METAANALYSIS OF PATIENTS TREATED WITH FLUOXETINE OR PLACEBO

      International clinical psychopharmacology
    85. HEILIGENSTEIN JH; FARIES DE; RUSH AJ; ANDERSEN JS; PANDE AC; ROFFWARG HP; DUNNER D; GILLIN JC; JAMES SP; LAHMEYER H; ZAJECKA J; TOLLEFSON GD; GARDNER DM
      LATENCY TO RAPID EYE-MOVEMENT SLEEP AS A PREDICTOR OF TREATMENT RESPONSE TO FLUOXETINE AND PLACEBO IN NONPSYCHOTIC DEPRESSED OUTPATIENTS

      Psychiatry research
    86. HEILIGENSTEIN JH; TOLLEFSON GD; FARIES DE
      RESPONSE PATTERNS OF DEPRESSED OUTPATIENTS WITH AND WITHOUT MELANCHOLIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF FLUOXETINE VERSUS PLACEBO

      Journal of affective disorders
    87. TOLLEFSON GD; HOLMAN SL; SAYLER ME; POTVIN JH
      FLUOXETINE, PLACEBO, AND TRICYCLIC ANTIDEPRESSANTS IN MAJOR DEPRESSION WITH AND WITHOUT ANXIOUS FEATURES

      The Journal of clinical psychiatry
    88. TOLLEFSON GD; BIRKETT M; KORAN L; GENDUSO L
      CONTINUATION TREATMENT OF OCD - DOUBLE-BLIND AND OPEN-LABEL EXPERIENCE WITH FLUOXETINE

      The Journal of clinical psychiatry
    89. FREY WH; EMORY CR; WIEBENGA ME; SAXENA S; CARDELLI D; ALA TA; TOLLEFSON GD
      INHIBITOR OF ANTAGONIST BINDING TO THE MUSCARINIC RECEPTOR IS ELEVATED IN ALZHEIMERS BRAIN

      Brain research
    90. TOLLEFSON GD; BEASLEY CM; TRAN PV; SANGER T
      OLANZAPINE - A NOVEL ANTIPSYCHOTIC WITH A BROAD-SPECTRUM PROFILE

      Biological psychiatry
    91. TOLLEFSON GD; RAMPEY AH; POTVIN JH; JENIKE MA; RUSH AJ; DOMINGUEZ RA; KORAN LM; SHEAR MK; GOODMAN W; GENDUSO LA
      A MULTICENTER INVESTIGATION OF FIXED-DOSE FLUOXETINE IN THE TREATMENTOF OBSESSIVE-COMPULSIVE DISORDER

      Archives of general psychiatry
    92. TOLLEFSON GD; RAMPEY AH; POTVIN JH; JENIKE MA; RUSH AJ; DOMINGUEZ RA; KORAN LM; SHEAR MK; GOODMAN W; GENDUSO LA
      A MULTICENTER INVESTIGATION OF FIXED-DOSE FLUOXETINE IN THE TREATMENTOF OBSESSIVE-COMPULSIVE-DISORDER (VOL 51, PG 559, 1994)

      Archives of general psychiatry
    93. TOLLEFSON GD
      NEUROPEPTIDE CANDIDATES - CLINICAL INDICATIONS AND CURRENT DRUG DEVELOPMENT

      Neuropsychopharmacology
    94. TOLLEFSON GD
      CCK ANTAGONIST AND OTHER RELATED NEUROPEPTIDES AS ANXIOLYTICS

      Neuropsychopharmacology
    95. HEILIGENSTEIN JH; TOLLEFSON GD; FARIES DE
      A DOUBLE-BLIND TRIAL OF FLUOXETINE, 20 MG, AND PLACEBO IN OUT-PATIENTS WITH DSM-III-R MAJOR DEPRESSION AND MELANCHOLIA

      International clinical psychopharmacology
    96. TOLLEFSON GD; HOLMAN SL
      ANALYSIS OF THE HAMILTON-DEPRESSION-RATING-SCALE FACTORS FROM A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF FLUOXETINE IN GERIATRIC MAJOR DEPRESSION

      International clinical psychopharmacology
    97. TOLLEFSON GD; SOUETRE E; THOMANDER L; POTVIN JH
      COMORBID ANXIOUS SIGNS AND SYMPTOMS IN MAJOR DEPRESSION - IMPACT ON FUNCTIONAL WORK CAPACITY AND COMPARATIVE TREATMENT OUTCOMES

      International clinical psychopharmacology
    98. WOOD A; TOLLEFSON GD; BIRKETT M
      PHARMACOTHERAPY OF OBSESSIVE-COMPULSIVE DISORDER - EXPERIENCE WITH FLUOXETINE

      International clinical psychopharmacology
    99. STOKES PE; BECH P; GREDEN JF; TOLLEFSON GD
      ACUTE THERAPY OF DEPRESSION - DISCUSSION

      The Journal of clinical psychiatry
    100. HALE AS; GREDEN JF; BECH P; STOKES PE; LEONARD BE; TOLLEFSON GD
      ANTIDEPRESSANT MAINTENANCE MEDICATIONS - WHEN TO DISCONTINUE AND HOW TO STOP - DISCUSSION

      The Journal of clinical psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 21:57:38